Can You Package Cannabis While Pesticide Results Are Pending? Health Canada's Rules, Decoded

It is the question a Quality Assurance Person hears more than almost any other on the production floor. A lot of dried flower is drying, the schedule is tight, and the pesticide results are still with the laboratory. Can the team start packaging now and hold shipment until the certificate arrives, or does everything stop until the numbers come back? The honest answer surprises many licence holders, because Health Canada has been specific about what a licence holder may and may not do with cannabis before it has met the mandatory pesticide testing requirements.

Pesticide detection remains one of the most damaging recall categories in the Canadian cannabis sector, and the release decision sits at the centre of it. Get the timing wrong and you have unauthorized activity on a lot that has not met a legal precondition for sale. Get it right and you protect both the public and your licence. This guide decodes Health Canada's current mandatory pesticide testing requirements, sets out exactly which activities are permitted while results are pending, and shows how to build a release decision procedure that will hold up under inspection.

Executive summary

Under the Cannabis Regulations, a cultivation, processing or research licence holder cannot sell, distribute or export a lot or batch of cannabis until it has met the mandatory pesticide testing requirements. For a processing licence holder, that precondition also blocks using the cannabis, which Health Canada defines to include extracting, formulating, packaging and labelling. So the direct answer to the headline question is no: you cannot package a lot while its pesticide results are pending. You can, however, store it, sample it, test it, and carry out certain ancillary post-harvest steps. The distinction between permitted preparatory activity and prohibited value-adding activity is where quality systems succeed or fail.

The short answer: what you can and cannot do while results are pending

What it is. Mandatory pesticide testing is a legal precondition, not a quality nicety. A lot or batch has not met the requirements until it has been tested and has either returned results below the laboratory limit of quantification for every listed pesticide active ingredient, or returned a positive result that was reported to Health Canada and cleared for release. Until one of those two things is true, the lot is not eligible for the activities the regulations gate behind that precondition.

Why it matters. For a processing licence holder, Health Canada states plainly that the holder must not use, sell, distribute or export a received lot until it has first met the requirements, and gives the examples of extracting, formulating, packaging and labelling. Packaging is therefore off the table while results are pending. What remains available is the set of activities necessary to determine whether the lot meets the requirements, together with a narrow band of post-harvest handling for cultivators.

What to do. Treat the pending window as a quarantine and preparation window, not a production window. Use it to store the lot under controlled conditions, pull a representative sample, and get the sample to a licensed laboratory. The table below sets out the boundary.

Activity while pesticide results are pending	Cultivation licence holder	Processing licence holder
Store the lot under controlled conditions	Permitted	Permitted
Sample and send for pesticide testing	Permitted	Permitted
Ancillary post-harvest handling (drying, trimming, milling)	Permitted before testing	Permitted only where the holder also holds a cultivation licence, on cannabis it harvested
Extract, formulate, package or label	Not permitted until met	Not permitted until met
Sell, distribute or export	Not permitted until met	Not permitted until met

These distinctions come directly from Health Canada's Mandatory cannabis testing for pesticide active ingredients: Requirements. A cultivation licence holder that also processes should note that the post-harvest allowance covers its own harvested cannabis. It does not extend the packaging or extraction of that cannabis, which still waits for the lot to meet the requirements.

What Health Canada's mandatory pesticide testing actually requires

Direct answer. Mandatory pesticide testing requires that every lot or batch of cannabis be tested by a third-party analytical testing licence holder, on a representative sample, for all pesticide active ingredients on Health Canada's list, before the cannabis is sold, distributed or exported. A licence holder must show that none of the listed ingredients are present as the result of unauthorized treatment or contamination.

The regime traces back to 2017, when recalls of cannabis for medical purposes involving unauthorized pest control products prompted Health Canada to strengthen monitoring. Mandatory testing took effect on 2 January 2019. It sits on top of Part 5 and Part 6 of the Cannabis Regulations (SOR/2018-144), which set out the good production practices and the general rules for cannabis products, including residue limits for pest control products and tolerance limits drawn from Schedule B to the Food and Drugs Act.

Subsection 81(1) of the Regulations is the anchor. A licence holder cannot treat cannabis with a pest control product unless that product is registered or otherwise authorized for use on cannabis under the Pest Control Products Act. Everything else is prohibited. Health Canada's Pest control products for use on cannabis page and the Pesticides Regulatory Directorate label search tool are the authoritative sources for what is permitted. Mandatory testing is the verification layer that confirms the rule was followed.

When a lot has met the requirements

Health Canada considers a lot or batch to have met the requirements once it has been tested and it has either tested negative, meaning below the laboratory limit of quantification for all listed pesticide active ingredients, or tested positive, been reported to Health Canada, and Health Canada has concluded that no further measures or continued quarantine are needed. Once a lot meets the requirements, it does not need to be retested at later stages for the purposes of this regime. If a licence holder chooses to retest, any new positive result must be reported and the cannabis placed in quarantine while the review is pending.

Who must test, and at what point

A cultivation licence holder must not sell, distribute or export a lot of plants or seeds that is a cannabis product until it has met the requirements. A processing licence holder must not use a received lot until it has met the requirements, but may store, sample and test it to make that determination. A research licence holder conducting non-therapeutic research must ensure a lot meets the requirements before administering or distributing it to human participants. Cannabis from research and development activities cannot be sold, distributed, exported or administered unless it meets the requirements. Fresh or dried cannabis is intended to be tested before it reaches consumers or before it becomes an extract, topical or edible product.

The release decision: where QAPs get it wrong

Direct answer. The release decision is not simply whether the certificate of analysis is clean. It is whether the lot has met the full set of requirements, which includes correct sampling, testing by an independent licensed laboratory, reporting of any positive result, and resolution of any quarantine. A QAP who releases on a laboratory number without confirming those upstream steps is exposed even when the result itself is compliant.

A positive result is defined as a pesticide testing result equal to or exceeding the laboratory limit of quantification. When a lot returns a positive result, the licence holder must report it to Health Canada and hold the lot in quarantine while the review is pending. The lot does not become releasable simply because time has passed. It becomes releasable only if Health Canada concludes that no further measures or continued quarantine are required. Building that reporting and hold logic into the release SOP, rather than leaving it to memory under production pressure, is the single most valuable control a QAP can put in place.

When a positive result does appear, the investigation that follows must reach a genuine root cause rather than stopping at laboratory error. Our guidance on root cause investigations that survive inspection and on validated analytical methods for cannabis testing both feed directly into a defensible release file.

Sampling, laboratories and the List and limits

Direct answer. Testing must cover every pesticide active ingredient on Health Canada's List and limits, must be performed on a representative sample of each lot or batch, and must be conducted by a third-party laboratory that holds an analytical testing licence and reports independently of the requester.

Representative sampling is a frequent weak point. A sample must be proportional to and reflective of the whole lot. Composite samples that blend subsamples from multiple distinct lots into one analysis are not considered representative. The licence holder who requests the analysis must retain a portion of the analysed sample for at least one year after the last sale of any part of that lot, and the retained portion must be large enough for Health Canada to run its own pesticide analysis. Laboratory independence matters because the laboratory report can affect production outcomes, and the regulations require the testing body to be a distinct entity with separate facilities, equipment and trained staff.

Concept	What it means for release
Limit of quantification (LoQ)	A result at or above the laboratory LoQ is a positive result and triggers reporting and quarantine.
Representative sample	Must reflect the whole lot; composite samples across distinct lots are not acceptable.
Third-party laboratory	Must hold an analytical testing licence and report independently of the requester.
Retained sample	Keep a portion for at least one year after the last sale of the lot, sufficient for Health Canada re-analysis.

For a deeper treatment of representative sampling, see our guide to cannabis sampling requirements. When qualifying a laboratory, confirm its accreditation to ISO/IEC 17025 for the specific pesticide methods you rely on, not just its general licence status.

Common inspection findings and CAPA guidance

Health Canada inspections repeatedly surface the same weaknesses around pesticide testing and release. Our review of what inspection data reveals about GPP documentation shows that most findings are procedural rather than analytical. The recurring themes are worth pre-empting with targeted corrective and preventive action.

Value-adding before release. Extraction, formulation, packaging or labelling of a lot that has not met the requirements. CAPA: add a system hold that blocks these steps until the release status flag is set.
Positive results not reported. A result at or above the LoQ that was not reported to Health Canada. CAPA: make reporting a mandatory, logged step in the release workflow with a named responsible person.
Non-representative sampling. Composite or convenience samples that do not reflect the lot. CAPA: rewrite the sampling SOP with lot-proportional sampling and train samplers against it.
Retained samples missing or too small. No one-year retained portion, or one too small for re-analysis. CAPA: define retained-sample volumes and storage in the SOP and track them in inventory.
Unauthorized pest control product use. Use of a product not registered for cannabis under section 81(1). CAPA: lock purchasing and application to the authorized-product list and verify against the label search tool.

Compliance checklist

Use this checklist to test your pesticide testing and release controls against Health Canada's current expectations.

Every lot is tested for all pesticide active ingredients on the current List and limits before sale, distribution or export.
Testing is performed by a third-party analytical testing licence holder that reports independently.
Sampling is representative of the whole lot, with no cross-lot composites.
Lots with pending results are held in quarantine and blocked from extraction, formulation, packaging and labelling.
Any positive result at or above the LoQ is reported to Health Canada and the lot held until Health Canada concludes no further measures are needed.
A retained sample is kept for at least one year after the last sale of the lot, sufficient for Health Canada re-analysis.
Only pest control products registered or authorized for cannabis under the Pest Control Products Act are used, verified against the label search tool.
The release SOP names who signs off, on what evidence, and how the release flag is recorded in inventory.

Common mistakes

Packaging early to save time. Packaging or labelling a lot while results are pending, on the assumption that holding shipment keeps it legal. Using the cannabis is itself prohibited until the lot has met the requirements.
Treating a clean number as automatic release. Releasing on the certificate alone without confirming sampling, laboratory licence status and any reporting obligations.
Assuming quarantine ends on its own. Believing a reported positive lot can be released after a waiting period, rather than only after Health Canada concludes no further measures are needed.
Retesting without reporting. Retesting a lot and not reporting a new positive result, or not re-quarantining while the review is pending.

Frequently asked questions

Can I package cannabis while pesticide test results are pending in Canada?

No. A processing licence holder must not use a received lot until it has met the mandatory pesticide testing requirements, and Health Canada defines using to include extracting, formulating, packaging and labelling. You may store, sample and test the lot while results are pending, but not package it.

What can I lawfully do with a lot while results are pending?

You may store the lot under controlled conditions, take a representative sample and send it for testing. A cultivation licence holder may also carry out ancillary post-harvest steps such as drying, trimming and milling on its own harvested cannabis before testing.

Who is allowed to conduct mandatory cannabis pesticide testing?

A third-party laboratory that holds an analytical testing licence under the Cannabis Regulations must perform the testing. The laboratory must be a distinct entity that reports independently of the requester, with its own facilities, equipment and trained staff.

What counts as a positive pesticide result?

A positive result is a pesticide testing result equal to or exceeding the laboratory limit of quantification for a listed pesticide active ingredient. A positive result must be reported to Health Canada, and the lot held in quarantine while the review is pending.

Do I need to retest a lot at later production stages?

No. Once a lot has met the requirements, it does not need to be retested at later stages for the purposes of this regime. If you do choose to retest, you must report any new positive result and quarantine the cannabis while the review is pending.

How long must I keep the retained sample?

The licence holder who requests the analysis must keep a portion of the analysed sample for at least one year after the date of the last sale of any portion of the tested lot. The retained portion must be large enough for Health Canada to run its own pesticide analysis.

How MFLRC can help

MFLRC works with licensed cultivators, processors and analytical testing sites to make the pesticide release decision defensible. We act as your Quality Assurance Person or support your in-house QAP, rewrite release decision and quarantine control SOPs so they block value-adding activity until a lot has met the requirements, and qualify your laboratories and suppliers. We run good production practices gap assessments and mock inspections, build mock recall and recall programmes, and put reporting logic into your workflow so a positive result is never missed. Many licence holders find that the SOPs licensed facilities most often get wrong cluster around release and quarantine, which is exactly where a strong Good Production Practices foundation pays off.

Whether you are preparing for a Health Canada inspection or reacting to a detection, we can help you get ahead of it. Pair a release review with our guidance on passing a Health Canada cannabis inspection and on compliant integrated pest management, and you move from reacting to detections to preventing them.

Book a compliance review with MFLRC

Conclusion

The answer to whether you can package while pesticide results are pending is no, but the more useful answer is the map of what you can do: store, sample and test, and for cultivators, handle post-harvest. Treat the pending window as quarantine and preparation, keep value-adding activity behind the release flag, and build reporting and hold logic into the SOP rather than relying on memory. As the sector moves through the changes coming on 1 October 2026, a release decision that holds up under inspection is one of the highest-value controls a licence holder can own. Always confirm the current wording of Health Canada's mandatory testing publications before acting, because the requirements are updated from time to time.